drugset / Trial / NCT05684861

Serum TWEAK Levels in Acne Vulgaris

NCT05684861

Phase 2 Completed 150 enrolled South Valley University
RandomizedSingle-groupSingle-blindDiagnostic

Summary

Evaluate the serum level of TWEAK in patients with AV and their relations before and after treatment with isotretinoin.

Timeline

Start
2022-01-01
Primary completion
2022-12-20
Completion
2023-01-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Isotretinoin Other / unclassified Oral

Indications